Alaunos Therapeutics, Inc. Public Float
Alaunos Therapeutics, Inc. (TCRT) had Public Float of $9.61 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $9.61M.
- 2024-06-30: Entity Public Float $10.80M.
- 2023-06-30: Entity Public Float $94.76M.
- 2022-06-30: Entity Public Float $221.55M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $9.61M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $10.80M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $94.76M 10-K · filed 2024-04-01 |
| 2022-06-30 | $221.55M 10-K · filed 2023-03-07 |
| 2021-06-30 | $543.71B 10-K · filed 2022-03-30 |
| 2020-06-30 | $687.34M 10-K · filed 2021-03-01 |
| 2019-06-28 | $834.87M 10-K · filed 2020-03-02 |
| 2018-06-29 | $339.37M 10-K · filed 2019-03-05 |
| 2017-06-30 | $808.80M 10-K · filed 2018-03-01 |
| 2016-06-30 | $659.30M 10-K · filed 2017-02-16 |
| 2015-06-30 | $1.29B 10-K · filed 2016-02-24 |
| 2014-06-30 | $327.14M 10-K · filed 2015-02-26 |
| 2013-06-30 | $141.66M 10-K · filed 2014-03-03 |
| 2012-06-30 | $396.15M 10-K · filed 2013-03-18 |
| 2011-06-30 | $316.08M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |